CHRNA7 and Alzheimer disease: While the apparent expression of α7 nAChR in the AD homogenate was dramatically increased (258%) compared to the non-AD homogenate, the expression level of GluN1 was significantly decreased (36%) in the AD homogenate compared to the non-AD homogenate (Fig 2B and 2C).